247 related articles for article (PubMed ID: 8693289)
21. Human T cells express the C5a receptor and are chemoattracted to C5a.
Nataf S; Davoust N; Ames RS; Barnum SR
J Immunol; 1999 Apr; 162(7):4018-23. PubMed ID: 10201923
[TBL] [Abstract][Full Text] [Related]
22. Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor.
Soruri A; Grigat J; Kiafard Z; Zwirner J
BMC Immunol; 2008 Jun; 9():29. PubMed ID: 18559098
[TBL] [Abstract][Full Text] [Related]
23. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
Elsner J; Oppermann M; Kapp A
Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
[TBL] [Abstract][Full Text] [Related]
24. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin.
Buchner RR; Hugli TE; Ember JA; Morgan EL
J Immunol; 1995 Jul; 155(1):308-15. PubMed ID: 7541417
[TBL] [Abstract][Full Text] [Related]
25. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
26. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
27. Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells.
Christophe T; Rabiet MJ; Tardif M; Milcent MD; Boulay F
J Biol Chem; 2000 Jan; 275(3):1656-64. PubMed ID: 10636859
[TBL] [Abstract][Full Text] [Related]
28. Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils.
Eglite S; Plüss K; Dahinden CA
J Immunol; 2000 Aug; 165(4):2183-9. PubMed ID: 10925305
[TBL] [Abstract][Full Text] [Related]
29. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
30. C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assay.
Reis ES; Chen H; Sfyroera G; Monk PN; Köhl J; Ricklin D; Lambris JD
J Immunol; 2012 Nov; 189(10):4797-805. PubMed ID: 23041570
[TBL] [Abstract][Full Text] [Related]
31. 1,25(OH)2D3 and cAMP synergistically induce complement 5a receptor messenger RNA.
Rubin J; Biskobing D; Titus L; Thornton DL; Catherwood BD; Nanes MS
Am J Med Sci; 1996 Feb; 311(2):73-9. PubMed ID: 8615377
[TBL] [Abstract][Full Text] [Related]
32. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
[TBL] [Abstract][Full Text] [Related]
33. Analysis of C5a receptor by monoclonal antibody.
Watanabe H; Kuraya M; Kasukawa R; Yanagisawa H; Yanagisawa M; Fujita T
J Immunol Methods; 1995 Sep; 185(1):19-29. PubMed ID: 7665898
[TBL] [Abstract][Full Text] [Related]
34. Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.
Monari C; Kozel TR; Bistoni F; Vecchiarelli A
Infect Immun; 2002 Jul; 70(7):3363-70. PubMed ID: 12065474
[TBL] [Abstract][Full Text] [Related]
35. A functional C5a anaphylatoxin receptor in a teleost species.
Holland MC; Lambris JD
J Immunol; 2004 Jan; 172(1):349-55. PubMed ID: 14688343
[TBL] [Abstract][Full Text] [Related]
36. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats.
Abe M; Shibata K; Akatsu H; Shimizu N; Sakata N; Katsuragi T; Okada H
J Immunol; 2001 Oct; 167(8):4651-60. PubMed ID: 11591795
[TBL] [Abstract][Full Text] [Related]
37. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid.
Zahn S; Zwirner J; Spengler HP; Götze O
Eur J Immunol; 1997 Apr; 27(4):935-40. PubMed ID: 9130647
[TBL] [Abstract][Full Text] [Related]
38. C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in uticaria pigmentosa by immunohistochemistry.
Werfel T; Oppermann M; Begemann G; Götze O; Zwirner J
Arch Dermatol Res; 1997 Jan; 289(2):83-6. PubMed ID: 9049041
[TBL] [Abstract][Full Text] [Related]
39. Cloning and characterization of the guinea pig C5a anaphylatoxin receptor: interspecies diversity among the C5a receptors.
Fukuoka Y; Ember JA; Yasui A; Hugli TE
Int Immunol; 1998 Mar; 10(3):275-83. PubMed ID: 9576615
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.
West PW; Bahri R; Garcia-Rodriguez KM; Sweetland G; Wileman G; Shah R; Montero A; Rapley L; Bulfone-Paus S
Front Immunol; 2020; 11():615236. PubMed ID: 33597949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
